Cissus Quadrangularis + Teclistamab-cqyv
Teclistamab-cqyv brand name: Tecvayli.
We found no known interaction between Cissus Quadrangularis and Teclistamab-cqyv in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first. Additionally, although there is no interaction, the two are separately associated with some of the same side effects, which would make a new symptom harder to attribute to one or the other.
Cissus Quadrangularis and Teclistamab-cqyv
We checked these two against our interaction database. Here is what we found.
No Known Interaction Found
We did not find a documented interaction between Teclistamab-cqyv and Cissus Quadrangularis in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.
If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.
Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.
Cissus Quadrangularis safety at a glance
Safety guidance is general; always confirm with your pharmacist or doctor for your situation.
Why No Interaction Is Listed for Teclistamab-cqyv
Interactions in our licensed database are recorded against drug classes, not just single drug names. Teclistamab-cqyv is filed under 2 classifications — immunosuppressants, hepatotoxic drugs. Cissus Quadrangularis has documented interactions with 1 drug class — the most serious being antidiabetes drugs (moderate) — and none of Teclistamab-cqyv’s classifications are among them.
Classification data comes from our licensed Natural Medicines dataset. A medication can belong to classes beyond those recorded there, so this describes how the check was run — it is not a safety guarantee.
Cissus Quadrangularis Does Interact With Other Medications
Cissus Quadrangularis has 86 moderate known drug interactions in our database — Teclistamab-cqyv isn’t one of them. If you take anything else, check it against the full list below.
Check Another of Your Medications Against Cissus Quadrangularis
We haven’t checked that one against Cissus Quadrangularis yet — ask our pharmacists directly.
Covers the 2,830 medications we’ve checked against Cissus Quadrangularis. Pick one to open its full report.
What Teclistamab-cqyv Is Prescribed For, and What Cissus Quadrangularis Has Been Studied For
These two come up together because they touch the same health topic — not because they do the same job. Teclistamab-cqyv is a prescription medicine with approved uses on its FDA label. Cissus Quadrangularis is a supplement: what follows is what researchers have looked at it for, and how strong that evidence is.
Teclistamab-cqyv is prescribed for: Tecvayli (teclistamab-cqyv) injection is used to treat adults with relapsed or refractory multiple myeloma — a cancer of plasma cells in the bone marrow — whose disease has come back or stopped responding to earlier treatments. Tecvayli is approved in two settings: as monotherapy for patients who have received at least four prior lines of therapy (including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody); and in combination with daratumumab and hyaluronidase-fihj for patients who have received at least one prior line of therapy including a proteasome inhibitor and an immunomodulatory agent.
Cissus Quadrangularis has been studied for:
-
Cancer studied, not established Cissus Quadrangularis has been studied for this. Natural Medicines rates the evidence: Insufficient Reliable Evidence To Rate Read what the research shows
Cissus Quadrangularis for cancer
Although there has been interest in using oral Cissus quadrangularis for cancer, there is insufficient reliable information about the clinical effects of Cissus quadrangularis for this purpose.
Effectiveness ratings and the research summaries above are the verbatim record from the Natural Medicines database, which grades evidence from “Effective” down to “Insufficient Reliable Evidence To Rate”. A rating below the top of that scale means researchers have looked at it — not that it works, and never that it can stand in for a prescribed medicine. Do not stop or replace Teclistamab-cqyv on your own; if you are taking Cissus Quadrangularis for the same health topic, tell your prescriber, especially if the medicine is being adjusted to a target.
Questions About Cissus Quadrangularis or Teclistamab-cqyv
These are real questions from readers, answered by the pharmacists at HelloPharmacist — written by a person, not generated from a database. Each one covers Cissus Quadrangularis or Teclistamab-cqyv, not necessarily both, but if one is close to what you were about to ask it will usually go further than a database entry can:
Not quite your question? Ask our pharmacists directly — it is free, there is no account required, and answers usually come back within 24 hours.
See Every Supplement That Interacts With Teclistamab-cqyv
This page covers Cissus Quadrangularis only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Teclistamab-cqyv page lists 89 supplements it has a documented interaction with, worst first, each one explained.
The most serious there right now: Beer (major), Siberian Cocklebur (major), Wine (major), Active Hexose Correlated Compound (ahcc) (moderate) and Alfalfa (moderate).
By severity: 3 major · 85 moderate · 1 minor.
From our pharmacist’s overview on the Teclistamab-cqyv page
“The sharpest supplement risk with teclistamab-cqyv (Tecvayli), an immune-directed treatment for multiple myeloma, is liver injury. All three major-rated interactions point there: Siberian cocklebur, an herb linked to cases of outright liver failure, along with beer and wine, since alcohol raises the chance of liver damage when taken al…”
Reviewed by 2 · Jul 18, 2026
Taking Cissus Quadrangularis as Part of a Dietary Supplement Product? Check It for Interactions
We hold 371 real supplement products containing Cissus Quadrangularis, each one broken down to its full ingredient list — and combination products often carry several ingredients besides Cissus Quadrangularis. Even though Cissus Quadrangularis itself has no known interaction with Teclistamab-cqyv, another ingredient on your label might. Find your product and we’ll check every ingredient on its label:
Where Cissus Quadrangularis and Teclistamab-cqyv Sit Against Everything Else
Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.
#298 of 1,452 supplements looked up here in the last 7 days
#1,348 of 2,830 medications looked up here in the last 7 days
Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.
Where does our data come from?
- Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
- Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Cissus Quadrangularis reference on this page ↓
- Freshness: we automatically re-check this combination every week — this pair was last verified September 13, 2026. The Cissus Quadrangularis and Teclistamab-cqyv records this page draws on were last updated July 10, 2026.
- What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
About Cissus Quadrangularis
What is Cissus Quadrangularis?
- Bone fracture healing
- Joint pain and bone health
- Weight management
- Blood sugar support
- Digestive complaints
Cissus quadrangularis is a traditional vine used mainly for bone health, joint pain, and weight management. Most of the supporting evidence comes from animal studies and a small number of human trials, so its benefits are not firmly proven. It appears reasonably well tolerated in the short term, but people who are pregnant, breastfeeding, or managing chronic conditions should talk to a doctor or pharmacist first.
Cissus quadrangularis · Vitaceae · Stems, leaves, and roots · Capsules, tablets, powder, extracts, and topical preparations
An interaction check asks whether these two react with each other — it does not ask whether Cissus Quadrangularis is a good idea for someone in your situation. Here is what our Cissus Quadrangularis record says about it on its own.
Cissus Quadrangularis: dosing
There is no official, standardized dose for Cissus quadrangularis. Products differ widely in their strength and how they are prepared, which makes a single recommended dose hard to give.The best approach is to follow the directions on the product label and not exceed the suggested amount. A pharmacist or doctor can help you decide whether a product and dose make sense for you, especially if you take other medicines or have health conditions.
From our Cissus Quadrangularis monograph — the full record covers uses, side effects and every documented interaction.
About Teclistamab-cqyv Injection
What Is Teclistamab-cqyv Injection Used For?
Brand name: Tecvayli
Tecvayli (teclistamab-cqyv) injection is used to treat adults with relapsed or refractory multiple myeloma — a cancer of plasma cells in the bone marrow — whose disease has come back or stopped responding to earlier treatments.
Tecvayli is approved in two settings: as monotherapy for patients who have received at least four prior lines of therapy (including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody); and in combination with daratumumab and hyaluronidase-fihj for patients who have received at least one prior line of therapy including a proteasome inhibitor and an immunomodulatory agent.
Other Drugs & Cissus Quadrangularis
Browse every other medication we’ve checked against Cissus Quadrangularis — both the ones with a known interaction and the ones without. Select any drug for the full detail.
No drugs match “”.
86 interactions
- Insulin (rdna) ›
- Glyburide ›
- Insulin (pork) ›
- Insulin (human) ›
- Acarbose ›
- Insulin Glargine ›
- Semaglutide ›
- Chlorpropamide ›
- Exenatide ›
- Glipizide ›
- Glucagon ›
- Insulin Lispro ›
- Metformin ›
- Repaglinide ›
- Sitagliptin ›
- Tirzepatide ›
- Acetohexamide ›
- Albiglutide ›
- Alogliptin ›
- Canagliflozin ›
- Dapagliflozin ›
- Dasiglucagon Hydrochloride ›
- Dulaglutide ›
- Empagliflozin ›
- Ertugliflozin ›
- Exenatide Synthetic ›
- Gliclazide ›
- Glimepiride ›
- Glucose ›
- Inhaled Insulin ›
- Insulin ›
- Insulin (bovine) ›
- Insulin Aspart ›
- Insulin Degludec ›
- Insulin Determir ›
- Insulin Glargine (rdna) ›
- Insulin Glargine Recombinant ›
- Insulin Glulisine (rdna) ›
- Insulin Lispro Recombinant ›
- Insulin Lispro-aabc ›
- Linagliptin ›
- Liraglutide ›
- Liraglutide Recombinant ›
- Lixisenatide ›
- Metformin Hydrochloride ›
- Metformin Xr ›
- Miglitol ›
- Muraglitazar ›
- Nateglinide ›
- Pioglitazone ›
- Pramlintide ›
- Rosiglitazone Maleate ›
- Saxagliptin ›
- Sotagliflozin ›
- Tobutamide ›
- Tolazamide ›
- Tolbutamide ›
- Troglitazone ›
- Vildagliptin ›
- Metformin, Sitagliptin ›
Showing 60 of 86 moderate interactions — see all 86 on the Cissus Quadrangularis page.
No interaction 2,743 drugs checked — show the list
We also checked Cissus Quadrangularis against these medications and found no known interaction in our sources. Open any page to confirm.
- Apixaban ›
- Levothyroxine ›
- Amlodipine ›
- Methylphenidate ›
- Warfarin ›
- Sertraline ›
- Testosterone ›
- Losartan Potassium ›
- Metoprolol ›
- Aspirin ›
- Ivermectin ›
- Rivaroxaban ›
- Rosuvastatin ›
- Escitalopram ›
- Acetaminophen ›
- Tadalafil ›
- Clopidogrel ›
- Atorvastatin ›
- Docusate ›
- Valacyclovir ›
- Abemaciclib ›
- Hydroxyurea ›
- Methamphetamine ›
- Ibuprofen ›
- Sumatriptan ›
- Warfarin Sodium ›
- Prednisone ›
- Propranolol ›
- Bupropion ›
- Lisdexamfetamine ›
- Amoxicillin ›
- Acyclovir ›
- Lisinopril ›
- Bendamustine ›
- Amitriptyline ›
- Doxycycline ›
- Methotrexate ›
- Fluoxetine ›
- Lamotrigine ›
- Amphetamine ›
- Gabapentin ›
- Pregabalin ›
- Acetaminophen, Codeine ›
- Azithromycin ›
- Dextroamphetamine ›
- Isotretinoin ›
- Clonazepam ›
- Omeprazole ›
- Methylene Blue ›
- Quetiapine ›
- Amlodipine Besylate ›
- Duloxetine ›
- Letrozole ›
- Buspirone ›
- Citalopram ›
- Naproxen ›
- Ciprofloxacin ›
- Bisoprolol ›
- Levothyroxine, Liothyronine ›
- Acetaminophen, Oxycodone ›
Showing the 60 most looked-up of 2,743 medications checked with no known interaction — see the full Cissus Quadrangularis list.
Cissus Quadrangularis References
The 5 references that drive our Cissus Quadrangularis monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.
- Oben J, Kuate D, Agbor G, et al. The use of a Cissus quadrangularis formulation in the management of weight loss and metabolic syndrome. Lipids Health Dis 2006, 5:24.
- Oben JE, Ngondi JL, Momo CN, et al. The use of Cissus quadrangularis/Irvingia gabonensis combination in the management of weight loss: a double-blind placebo-controlled study. Lipids Health Dis 2008;7:12.
- Panpimanmas, S., Sithipongsri, S., Sukdanon, C., and Manmee, C. Experimental comparative study of the efficacy and side effects of Cissus quadrangularis L. (Vitaceae) to Daflon (Servier) and placebo in the treatment of acute hemorrhoids. J Med Assoc.Thai
- Nash R, Azantsa B, Kuate D, Singh H, Oben J. The use of a stem and leaf aqueous extract of Cissus quadrangularis (CQR-300) to reduce body fat and other components of metabolic syndrome in overweight participants. J Altern Complement Med. 2019;25(1):98-106
- Benjawan S, Nimitphong H, Tragulpiankit P, Musigavong O, Prathanturarug S, Pathomwichaiwat T. The effect of Cissus quadrangularis L. on delaying bone loss in postmenopausal women with osteopenia: A randomized placebo-controlled trial. Phytomedicine 2022;1 PubMed
Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.
Taking Cissus Quadrangularis and Teclistamab-cqyv Together: Common Questions
Is it safe to take Cissus Quadrangularis with Teclistamab-cqyv?
Do Cissus Quadrangularis and Teclistamab-cqyv have any of the same side effects?
Are Cissus Quadrangularis and Teclistamab-cqyv used for the same thing?
How was the Cissus Quadrangularis and Teclistamab-cqyv combination checked?
Does Cissus Quadrangularis interact with any other medications?
Does Teclistamab-cqyv interact with any supplements?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Keep Exploring
Still Have a Question About Teclistamab-cqyv and Cissus Quadrangularis?
Our pharmacists answer your medication & supplement questions — free.
This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.